Identification of virulence determinants in uropathogenic Proteus mirabilis using signature-tagged mutagenesis

Journal of Medical Microbiology

Volumn 57, Issue 9, 2008, Pages 1068-1078

  Himpsl, Stephanie D ^a   Lockatell, C Virginia ^b   Hebel, J Richard ^b   Johnson, David E ^b,c   Mobley, Harry L T ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c Research Service   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DSBA PROTEIN; GLYCOSYLTRANSFERASE; HEMOLYSIN; PEPTIDYLPROLYL ISOMERASE; UREASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL FLAGELLUM; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CBA MOUSE; CONTROLLED STUDY; FIMBRIA; GENE DISRUPTION; GENE INSERTION; GRAM NEGATIVE INFECTION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; TRANSPOSON; URINARY TRACT INFECTION; WILD TYPE;

ANIMALS; BACTERIAL PROTEINS; CELL SURFACE EXTENSIONS; DNA TRANSPOSABLE ELEMENTS; GENE EXPRESSION REGULATION, BACTERIAL; MICE; MICE, INBRED CBA; MUTAGENESIS; PHENOTYPE; PROTEUS MIRABILIS; URINARY TRACT INFECTIONS; VIRULENCE; VIRULENCE FACTORS;

EID: 51149103532     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.2008/002071-0     Document Type: Article

References (80)

1. Alamuri, P. & Mobley, H. L. T. (2008). A novel autotransporter of uropathogenic Proteus mirabilis is both a cytotoxin and an agglutinin. Mol Microbiol 68, 997-1017.
2. Allison, C., Coleman, N., Jones, P. L. & Hughes, C. (1992a). Ability of Proteus mirabilis to invade human urothelial cells is coupled to motility and swarming differentiation. Infect Immun 60, 4740-4746.
3. Allison, C., Lai, H. C. & Hughes, C. (1992b). Co-ordinate expression of virulence genes during swarm-cell differentiation and population migration of Proteus mirabilis. Mol Microbiol 6, 1583-1591.
4. Allison, C., Emody, L., Coleman, N. & Hughes, C. (1994). The role of swarm cell differentiation and multicellular migration in the uropathogenicity of Proteus mirabilis. J Infect Dis 169, 1155-1158.
5. Alteri, C. J. & Mobley, H. L. (2007). Quantitative profile of the uropathogenic Escherichia coli outer membrane proteome during growth in human urine. Infect Immun 75, 2679-2688.
6. Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. (1990). Basic local alignment search tool. J Mol Biol 215, 403-410.
7. Bahrani, F. K., Johnson, D. E., Robbins, D. & Mobley, H. L. (1991). Proteus mirabilis flagella and MR/P fimbriae: isolation, purification, N-terminal analysis, and serum antibody response following experimental urinary tract infection. Infect Immun 59, 3574-3580.
8. Bahrani, F. K., Massad, G., Lockatell, C. V., Johnson, D. E., Russell, R. G., Warren, J. W. & Mobley, H. L. (1994). Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection. Infect Immun 62, 3363-3371.
9. Bahrani-Mougeot, F. K., Buckles, E. L., Lockatell, C. V., Hebel, J. R., Johnson, D. E., Tang, C. M. & Donnenberg, M. S. (2002). Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract. Mol Microbiol 45, 1079-1093.
10. Belas, R. & Suvanasuthi, R. (2005). The ability of Proteus mirabilis to sense surfaces and regulate virulence gene expression involves FliL, a flagellar basal body protein. J Bacteriol 187, 6789-6803.
11. Belas, R., Erskine, D. & Flaherty, D. (1991). Transposon mutagenesis in Proteus mirabilis. J Bacteriol 173, 6289-6293.
12. Belas, R., Schneider, R. & Melch, M. (1998). Characterization of Proteus mirabilis precocious swarming mutants: identification of rsbA, encoding a regulator of swarming behavior. J Bacteriol 180, 6126-6139.
13. Bijlsma, I. G., van Dijk, L., Kusters, J. G. & Gaastra, W. (1995). Nucleotide sequences of two fimbrial major subunit genes, pmpA and ucaA, from canine-uropathogenic Proteus mirabilis strains. Microbiology 141, 1349-1357.
14. Bondarenko, V. M., Parkhomenko, L. V. & Koval'chuk, V. K. (1993). The secreted proteolytic enzymes of Proteus mirabilis. Zh Mikrobiol Epidemiol Immunobiol 2, 41-47.
15. Braun, V., Gaisser, S., Herrmann, C., Kampfenkel, K., Killmann, H. & Traub, I. (1996). Energy-coupled transport across the outer membrane of Escherichia coli: ExbB binds ExbD and TonB in vitro, and leucine 132 in the periplasmic region and aspartate 25 in the transmembrane region are important for ExbD activity. J Bacteriol 178, 2836-2845.
16. Burall, L. S., Harro, J. M., Li, X., Lockatell, C. V., Himpsl, S. D., Hebel, J. R., Johnson, D. E. & Mobley, H. L. (2004). Proteus mirabilis genes that contribute to pathogenesis of urinary tract infection: identification of 25 signature-tagged mutants attenuated at least 100-fold. Infect Immun 72, 2922-2938.
17. Chiang, S. L. & Mekalanos, J. J. (1998). Use of signature-tagged transposon mutagenesis to identify Vibrio cholerae genes critical for colonization. Mol Microbiol 27, 797-805.
18. Chippendale, G. R., Warren, J. W., Trifillis, A. L. & Mobley, H. L. (1994). Internalization of Proteus mirabilis by human renal epithelial cells. Infect Immun 62, 3115-3121.
19. Dattelbaum, J. D., Lockatell, C. V., Johnson, D. E. & Mobley, H. L. (2003). UreR, the transcriptional activator of the Proteus mirabilis urease gene cluster, is required for urease activity and virulence in experimental urinary tract infections. Infect Immun 71, 1026-1030.
20. de Lorenzo, V., Herrero, M., Jakubzik, U. & Timmis, K. N. (1990). Mini-Tn5 transposon derivatives for insertion mutagenesis, promoter probing, and chromosomal insertion of cloned DNA in Gram-negative eubacteria. J Bacteriol 172, 6568-6572.
21. Fischer, E., Gunter, K. & Braun, V. (1989). Involvement of ExbB and TonB in transport across the outer membrane of Escherichia coli: phenotypic complementation of exb mutants by overexpressed tonB and physical stabilization of TonB by ExbB. J Bacteriol 171, 5127-5134.
22. Goller, C., Wang, X., Itoh, Y. & Romeo, T. (2006). The cation-responsive protein NhaR of Escherichia coli activates pgaABCD transcription, required for production of the biofilm adhesin poly-beta-1,6-N-acetyl-D-glucosamine. J Bacteriol 188, 8022-8032.
23. Griffith, D. P., Musher, D. M. & Itin, C. (1976). Urease. The primary cause of infection-induced urinary stones. Invest Urol 13, 346-350.
24. Grunenfelder, B., Gehrig, S. & Jenal, U. (2003). Role of the cytoplasmic C terminus of the FliF motor protein in flagellar assembly and rotation. J Bacteriol 185, 1624-1633.
25. Gygi, D., Rahman, M. M., Lai, H. C., Carlson, R., Guard-Petter, J. & Hughes, C. (1995). A cell-surface polysaccharide that facilitates rapid population migration by differentiated swarm cells of Proteus mirabilis. Mol Microbiol 17, 1167-1175.
26. Hagberg, L., Engberg, I., Freter, R., Lam, J., Olling, S. & Svanborg Eden, C. (1983). Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect Immun 40, 273-283.
27. Hensel, M., Shea, J. E., Gleeson, C., Jones, M. D., Dalton, E. & Holden, D. W. (1995). Simultaneous identification of bacterial virulence genes by negative selection. Science 269, 400-403.
28. Herrero, M., de Lorenzo, V. & Timmis, K. N. (1990). Transposon vectors containing non-antibiotic resistance selection markers for cloning and stable chromosomal insertion of foreign genes in Gram-negative bacteria. J Bacteriol 172, 6557-6567.
29. Hu, L. T., Nicholson, E. B., Jones, B. D., Lynch, M. J. & Mobley, H. L. (1990). Morganella morganii urease: purification, characterization, and isolation of gene sequences. J Bacteriol 172, 3073-3080.
30. Hunstad, D. A., Justice, S. S., Hung, C. S., Lauer, S. R. & Hultgren, S. J. (2005). Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli. Infect Immun 73, 3999-4006.
31. Itoh, Y., Wang, X., Hinnebusch, B. J., Preston, J. F., III & Romeo, T. (2005). Depolymerization of beta-1,6-N-acetyl-D- glucosamine disrupts the integrity of diverse bacterial biofilms. J Bacteriol 187, 382-387.
32. Jacobsen, S. M., Lane, M. C., Harro, J. M., Shirtliff, M. E. & Mobley, H. L. (2008). The high-affinity phosphate transporter Pst is a virulence factor for Proteus mirabilis during complicated urinary tract infection. FEMS Immunol Med Microbiol 52, 180-193.
33. Johnson, D. E., Russell, R. G., Lockatell, C. V., Zulty, J. C., Warren, J. W. & Mobley, H. L. (1993). Contribution of Proteus mirabilis urease to persistence, urolithiasis, and acute pyelonephritis in a mouse model of ascending urinary tract infection. Infect Immun 61, 2748-2754.
34. Jones, B. D. & Mobley, H. L. (1988). Proteus mirabilis urease: genetic organization, regulation, and expression of structural genes. J Bacteriol 170, 3342-3349.
35. Jones, B. D., Lockatell, C. V., Johnson, D. E., Warren, J. W. & Mobley, H. L. (1990). Construction of a urease-negative mutant of Proteus mirabilis: analysis of virulence in a mouse model of ascending urinary tract infection. Infect Immun 58, 1120-1123.
36. Justice, S. S., Hunstad, D. A., Harper, J. R., Duguay, A. R., Pinkner, J. S., Bann, J., Frieden, C., Silhavy, T. J. & Hultgren, S. J. (2005). Periplasmic peptidyl prolyl cis-trans isomerases are not essential for viability, but SurA is required for pilus biogenesis in Escherichia coli. J Bacteriol 187, 7680-7686.
37. Justice, S. S., Lauer, S. R., Hultgren, S. J. & Hunstad, D. A. (2006). Maturation of intracellular Escherichia coli communities requires SurA. Infect Immun 74, 4793-4800.
38. Klena, J. D., Ashford, R. S., II & Schnaitman, C. A. (1992). Role of Escherichia coli K-12 rfa genes and the rfp gene of Shigella dysenteriae 1 in generation of lipopolysaccharide core heterogeneity and attachment of O antigen. J Bacteriol 174, 7297-7307.
39. Komoriya, K., Shibano, N., Higano, T., Azuma, N., Yamaguchi, S. & Aizawa, S. I. (1999). Flagellar proteins and type III-exported virulence factors are the predominant proteins secreted into the culture media of Salmonella typhimurium. Mol Microbiol 34, 767-779.
40. Kubori, T., Shimamoto, N., Yamaguchi, S., Namba, K. & Aizawa, S. (1992). Morphological pathway of flagellar assembly in Salmonella typhimurium. J Mol Biol 226, 433-446.
41. Li, X., Johnson, D. E. & Mobley, H. L. (1999). Requirement of MrpH for mannose-resistant Proteus-like fimbria-mediated hemagglutination by Proteus mirabilis. Infect Immun 67, 2822-2833.
42. Li, X., Lockatell, C. V., Johnson, D. E. & Mobley, H. L. (2002). Identification of Mrp1 as the sole recombinase that regulates the phase variation of MR/P fimbria, a bladder colonization factor of uropathogenic Proteus mirabilis. Mol Microbiol 45, 865-874.
43. Liaw, S. J., Lai, H. C. & Wang, W. B. (2004). Modulation of swarming and virulence by fatty acids through the RsbA protein in Proteus mirabilis. Infect Immun 72, 6836-6845.
44. Loomes, L. M., Kerr, M. A. & Senior, B. W. (1993). The cleavage of immunoglobulin G in vitro and in vivo by a proteinase secreted by the urinary tract pathogen Proteus mirabilis. J Med Microbiol 39, 225-232.
45. MacLachlan, P. R., Kadam, S. K. & Sanderson, K. E. (1991). Cloning, characterization, and DNA sequence of the rfaLK region for lipopolysaccharide synthesis in Salmonella typhimurium LT2. J Bacteriol 173, 7151-7163.
46. Massad, G. & Mobley, H. L. (1994). Genetic organization and complete sequence of the Proteus mirabilis pmf fimbrial operon. Gene 150, 101-104.
47. Massad, G., Bahrani, F. K. & Mobley, H. L. (1994a). Proteus mirabilis fimbriae: identification, isolation, and characterization of a new ambient-temperature fimbria. Infect Immun 62, 1989-1994.
48. Massad, G., Lockatell, C. V., Johnson, D. E. & Mobley, H. L. (1994b). Proteus mirabilis fimbriae: construction of an isogenic pmfA mutant and analysis of virulence in a CBA mouse model of ascending urinary tract infection. Infect Immun 62, 536-542.
49. Mazurkiewicz, P., Tang, C. M., Boone, C. & Holden, D. W. (2006). Signature-tagged mutagenesis: barcoding mutants for genome-wide screens. Nat Rev Genet 7, 929-939.
50. Mei, J. M., Nourbakhsh, F., Ford, C. W. & Holden, D. W. (1997). Identification of Staphylococcus aureus virulence genes in a murine model of bacteraemia using signature-tagged mutagenesis. Mol Microbiol 26, 399-407.
51. Mobley, H. L. & Chippendale, G. R. (1990). Hemagglutinin, urease, and hemolysin production by Proteus mirabilis from clinical sources. J Infect Dis 161, 525-530.
52. Mobley, H. L. & Hausinger, R. P. (1989). Microbial ureases: significance, regulation, and molecular characterization. Microbiol Rev 53, 85-108.
53. Mobley, H. L. & Warren, J. W. (1987). Urease-positive bacteriuria and obstruction of long-term urinary catheters. J Clin Microbiol 25, 2216-2217.
54. Mobley, H. L., Belas, R., Lockatell, V., Chippendale, G., Trifillis, A. L., Johnson, D. E. & Warren, J. W. (1996). Construction of a flagellum-negative mutant of Proteus mirabilis: effect on internalization by human renal epithelial cells and virulence in a mouse model of ascending urinary tract infection. Infect Immun 64, 5332-5340.
55. Parker, C. T., Pradel, E. & Schnaitman, C. A. (1992). Identification and sequences of the lipopolysaccharide core biosynthetic genes rfaQ, rfaP, and rfaG of Escherichia coli K-12. J Bacteriol 174, 930-934.
56. Pearson, M. M., Sebaihia, M., Churcher, C., Quail, M. A., Seshasayee, A. S., Abdellah, Z., Arrosmith, C., Atkin, B., Chillingworth, T. & other authors (2008). The complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility. J Bacteriol 190, 4027-4037.
57. Peerbooms, P. G., Verweij, A. M. & MacLaren, D. M. (1983). Investigation of the haemolytic activity of Proteus mirabilis strains. Antonie Van Leeuvjenhoek 49, 1-11.
58. Sanschaghn, F., Kukavica-Ibrulj, I. & Levesque, R. C. (2008). Essential genes in the infection model of Pseudomonas aeruginosa PCR-based signature-tagged mutagenesis. Methods Mol Biol 416, 61-82.
59. Sareneva, T., Holthofer, H. & Korhonen, T. K. (1990). Tissue-binding affinity of Proteus mirabilis fimbriae in the human urinary tract. Infect Immun 58, 3330-3336.
60. Schwan, W. R., Coulter, S. N., Ng, E. Y., Langhorne, M. H., Ritchie, H. D, Brody, L. L., Westbrock-Wadman, S., Bayer, A. S., Folger, K. R. & Stover, C. K. (1998). Identification and characterization of the PutP proline permease that contributes to in vivo survival of Staphylococcus aureus in animal models. Infect Immun 66, 567-572.
61. Senior, B. W., Albrechtsen, M. & Kerr, M. A. (1987). Proteus mirabilis strains of diverse type have IgA protease activity. J Med Microbiol 24, 175-180.
62. Setia, U., Serventi, I. & Lorenz, P. (1984). Bacteremia in a long-term care facility. Spectrum and mortality. Arch Intern Med 144, 1633-1635.
63. Shea, J. E., Hensel, M., Gleeson, C. & Holden, D. W. (1996). Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium. Proc Natl Acad Sci U S A 93, 2593-2597.
64. Swihart, K. G. & Welch, R. A. (1990). Cytotoxic activity of the Proteus hemolysin HpmA. Infect Immun 58, 1861-1869.
65. Tolson, D. L., Barrigar, D. L., McLean, R. J. & Altman, E. (1995). Expression of a nonagglutinating fimbria by Proteus mirabilis. Infect Immun 63, 1127-1129.
66. Tolson, D. L., Harrison, B. A., Latta, R. K., Lee, K. K. & Altman, E. (1997). The expression of nonagglutinating fimbriae and its role in Proteus mirabilis adherence to epithelial cells. Can J Microbiol 43, 709-717.
67. Walker, K. E., Moghaddame-Jafari, S., Lockatell, C. V., Johnson, D. & Belas, R. (1999). ZapA, the IgA-degrading metalloprotease of Proteus mirabilis, is a virulence factor expressed specifically in swarmer cells. Mol Microbiol 32, 825-836.
68. Wang, W. B., Chen, I. C., Jiang, S. S., Chen, H. R., Hsu, C. Y., Hsueh, P. R., Hsu, W. B. & Liaw, S. J. (2008). Role of RppA in the regulation of polymyxin B susceptibility, swarming, and virulence factor expression in Proteus mirabilis. Infect Immun 76, 2051-2062.
69. Warren, J. W., Tenney, J. H., Hoopes, J. M., Muncie, H. L. & Anthony, W. C. (1982). A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis 146, 719-723.
70. Warren, J. W., Damron, D., Tenney, J. H., Hoopes, J. M., Deforge, B. & Muncie, H. L., Jr (1987). Fever, bacteremia, and death as complications of bacteriuria in women with long-term urethral catheters. J Infect Dis 155, 1151-1158.
71. Wassif, C., Cheek, D. & Belas, R. (1995). Molecular analysis of a metalloprotease from Proteus mirabilis. J Bacteriol 177, 5790-5798.
72. Welch, R. A. (1987). Identification of two different hemolysin determinants in uropathogenic Proteus isolates. Infect Immun 55, 2183-2190.
73. Wells, T. J., Tree, J. J., Ulett, G. C. & Schembri, M. A. (2007). Autotransporter proteins: novel targets at the bacterial cell surface. FEMS Microbiol Lett 274, 163-172.
74. Wray, S. K., Hull, S. I., Cook, R. G., Barrish, J. & Hull, R. A. (1986). Identification and characterization of a uroepithelial cell adhesin from a uropathogenic isolate of Proteus mirabilis. Infect Immun 54, 43-49.
75. Wu, J. & Newton, A. (1997). Regulation of the Caulobacter flagellar gene hierarchy; not just for motility. Mol Microbiol 24, 233-239.
76. Zhao, H., Li, X., Johnson, D. E. & Mobley, H. L. (1999). Identification of protease and rpoN-associated genes of uropathogenic Proteus mirabilis by negative selection in a mouse model of ascending urinary tract infection. Microbiology 145, 185-195.
77. Zilsel, J., Ma, P. H. & Beatty, J. T. (1992). Derivation of a mathematical expression useful for the construction of complete genomic libraries. Gene 120, 89-92.
78. Zunino, P., Geymonat, L., Allen, A. G., Preston, A., Sosa, V. & Masked, D. J. (2001). New aspects of the role of MR/P fimbriae in Proteus mirabilis urinary tract infection. FEMS Immunol Med Microbiol 31, 113-120.
79. Zunino, P., Sosa, V., Allen, A. G., Preston, A., Schlapp, G. & Maskell, D. J. (2003). Proteus mirabilis fimbriae (PMF) are important for both bladder and kidney colonization in mice. Microbiology 149, 3231-3237.
80. Zunino, P., Sosa, V., Schlapp, G., Allen, A. G., Preston, A. & Maskell, D. J. (2007). Mannose-resistant Proteus-like and P. mirabilis fimbriae have specific and additive roles in P. mirabilis urinary tract infections. FEMS Immunol Med Microbiol 51, 125-133.